由ROS触发的水友性切换与pH响应的纳米载体协同作用,用于治疗糖尿病伤口
Bin Yin1, Yueying Fan1, Jinfu Li1
1Center of Burn & Plastic and Wound Healing Surgery, The First Affiliated Hospital of University of South China, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.
Regenerative biomaterials
|November 24, 2025
概括
这项研究介绍了一种智能水凝,通过释放药物来响应炎症和酸度,有效地治愈慢性糖尿病伤口. 这种新的双响应系统显著提高了伤口关闭率,并解决了关键的愈合障碍.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 纳米技术纳米技术
背景情况:
- 慢性糖尿病伤口表现出持续的炎症和氧化应激,阻碍愈合.
- 目前的治疗方法缺乏多动力机制和有效的药物输送,用于复杂的伤口环境.
研究的目的:
- 开发一种双响应的智能水凝 (GC-HA@ZIF-8@Cur) 用于慢性糖尿病伤口的协同治疗.
- 设计一种能够精确的系统,时空释放药物,针对炎症,氧化应激和血管再生.
主要方法:
- 制造一种ROS/pH双响应的水凝,其中包含含有黄素的,用 hialuronic 酸修饰的化物 imidazolate framework-8纳米颗粒 (HA@ZIF-8@Cur).
- 采用甲基化凝和酸移植奇托的水凝矩阵,对活性氧物种 (ROS) 和酸性条件有反应.
- 在实验模型中研究水凝调节免疫微环境,促进血管生成和增强糖尿病伤口愈合的能力.
主要成果:
- 在酸性条件下,GC-HA@ZIF-8@Cur水凝在ROS中表现出增强的水友性,导致黄素和Zn2+的级联释放.
- 显著下调促炎性因素 (IL-6,TNF-α) 和M1巨细胞极化,以及M2极化和IL-10上调.
- Zn2+促进了血管内皮生长因子 (VEGF) 的表达,加速了血管生成,并在第14天改善了伤口关闭的96.37%.
结论:
- 双响应的水凝系统为慢性伤口治疗提供了一种新的多目标联合交付策略.
- 这种智能水凝有效地解决了炎症,氧化应激和血管再生缺陷,显著提高了糖尿病伤口愈合.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
124
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
124
Site-Targeted Drug Delivery Systems: Polymeric Carriers
114
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
114


